Skip to content
Yog Pharma
Urology and men's healthAlpha-1A adrenergic blocker

Tamsulosin Hydrochloride is an alpha-1A adrenergic blocker indicated for signs and symptoms of benign prostatic hyperplasia. We supply it to US manufacturers of capsules.

CAS106463-17-6445.0 g/molC20H29ClN2O5S
2D structure of Tamsulosin Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 5362376) and FDA’s substance registry

CAS number

106463-17-6

Molecular formula

C20H29ClN2O5S

Molecular weight

445.0g/mol

FDA UNII

IUPAC name

5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride

InChIKey

ZZIZZTHXZRDOFM-XFULWGLBSA-N

Appearance
White or almost white crystalline powder that melts with decomposition at about 230 °C.
Solubility
Sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

A low-dose, potent API: one capsule holds 0.4 mg. It is the single R-enantiomer, so check the limit for the S-enantiomer and ask how the source handles containment.

On the US market

Reference product
FlomaxNDA 020579
Approved ANDAs
11 with a marketed product
Approved forms and strengths
  • Capsule 0.4 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com